• 100+

    The UK’s most active investor in UK university spin-outs

  • £300M

    Over £300m raised; invested into over 100 companies

  • 17 wins

    Award winning manager with track record of delivering returns

  • £1.1Bn

    Part of FTSE 250 sector specialist group with £1.1bn net assets

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

Covid-19 Update: We continue to operate as usual, supporting the best of our technology companies. We accept applications by email and are having video updates with investors and advisers. Further details here.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Moray Wright
Harriet Doherty
Georgia Docker
Meet the team

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

Oxford Quantum Circuits

OQC’s mission is to put quantum in the hands of humanity, to solve some of the world’s most challenging problems. They have built the most advanced and only commercially available quantum computer in the UK and achieved performance parameters as good as or better than key competitors at a fraction of the cost.

Ikarovec

Ikarovec was formed to commercialise certain orphan assets from Quethera, a spin-out from the University of Cambridge, which was acquired by Astellas Pharma Inc. Initially Ikarovec is working on early stage assets intended for the treatment of diabetic macular edama.

Cloud Sustainability

Cloud Sustainability is a cloud based software platform that changes the way sustainability knowledge, consultancy and training is delivered. It reduces costs, educates and empowers the user, creating self-sufficiency and delivering long-term sustainable benefit.

View Portfolio